For the first time, a drug treatment has been shown to extend the lives of women with metastatic breast cancer after Herceptin alone failed.

Blood levels of LDL “bad” cholesterol increase dramatically in women around the time of menopause, and the rise is not related to aging, new research confirms.

Moderate intake of soy foods by breast cancer survivors appears to be not only safe but beneficial, according to a new study.

Last year the FDA warned of increased suicide risk in patients treated with epilepsy drugs for bipolar disorder. But a new study finds fewer suicides in treated patients.

Serious reactions after receiving the H1N1 swine flu vaccine are rare and not significantly higher than those seen from the seasonal flu vaccine, according to a briefing at the CDC today.

Researchers report that diabetes patients who used sulfonylureas had a higher risk of death from all causes and a higher risk of heart failure than diabetes patients who used the most widely prescribed diabetes drug — metformin.

T-cell immune responses destroy insulin-making beta cells in type 1 diabetes — but new studies show that targeting B cells slows beta-cell destruction and delays diabetes.

If nothing is done, the number of Americans with diabetes will nearly double over the next 25 years and spending on the disease will nearly triple, a new study finds.

A new study of the weight loss drug Meridia is in the hands of FDA regulators, who’ve released an early communication based on preliminary data: certain patients taking the drug may have a higher risk of heart attacks, strokes, and other serious cardiovascular problems.

Related Blogs

• Related Blogs on FDA Reviews Safety of Diet Drug Meridia

A new study suggests that an immune system response may be the real culprit behind reflux esophagitis.

Related Blogs

• Related Blogs on GERD-Related Injury May Have Immune Trigger